secwatch.observer — SEC 8-K summary
======================================

Issuer:     SkinHealth Systems Inc. (SKIN)
CIK:        0001818093
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0001628280-26-032099
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SkinHealth Q1 revenue $64.9M, adjusted EBITDA $8.5M; cuts FY revenue outlook
----------------------------------------------------------------------------

- Net sales $64.9M (-6.8% YoY); net loss improved to ($6.6M) from ($10.1M).
- Adjusted EBITDA $8.5M, margin 13.1% vs 10.4% YoY; gross margin 68.5% vs 69.8%.
- Delivery systems sold 746 (down 13.5% YoY); active install base grew to 36,419.
- CEO Pedro Malha cited market challenges and lowered full-year revenue outlook.
- Adjusted gross margin improved to 72.2% from 71.9% on cost discipline.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818093/000162828026032099/0001628280-26-032099-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818093/000162828026032099/skin-20260507.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-032099

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer